Cancerfonden grant to Ruth Palmer

Ruth Palmer has once again been trusted by Cancerfonden to conduct high quality research.

The project “Decoding ALK Signaling: Harnessing Model Systems for Effective Therapeutic targeting of ALK-Driven Neuroblastoma” has been awarded 5.25 million SEK by Cancerfonden. The lab thanks the foundation for their trust and we are eager to continue our work of finding novel treatment strategies for Neuroblastoma patients.